Gene expression profiles identify both MyD88-independent and MyD88-dependent pathways involved in the maturation of dendritic cells mediated by heparan sulfate: A novel adjuvant

Human Vaccines and Immunotherapeutics

Volumn 10, Issue 12, 2014, Pages 3711-3721

  Wu, Meini ^a   Wang, Haixuan ^a   Shi, Jiandong ^a   Sun, Jing ^a   Duan, Zhiqing ^a   Li, Yanhan ^a   Li, Jianfang ^a   Hu, Ningzhu ^a   Wei, Yiju ^a   Chen, Yang ^a,b   Hu, Yunzhang ^a  

^a INSTITUTE OF MEDICAL BIOLOGY   (China)

^b TSINGHUA NATIONAL LABORATORY FOR INFORMATION SCIENCE AND TECHNOLOGY   (China)

Author keywords

Dendritic cells; Gene expression profile; Heparan sulfate; Humoral immune response; Toll like receptor signaling pathway; Vaccine adjuvant

Indexed keywords

ALUMINUM POTASSIUM SULFATE; B7 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; FREUND ADJUVANT; HEPARAN SULFATE; HEPATITIS A VACCINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN G ANTIBODY; INTERFERON REGULATORY FACTOR 7; MYELOID DIFFERENTIATION FACTOR 88; RABIES VACCINE; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 3; IMMUNOLOGICAL ADJUVANT; MYD88 PROTEIN, MOUSE; TRANSCRIPTOME;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY TITER; ARTICLE; CELL MATURATION; CONTROLLED STUDY; DENDRITIC CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOGENICITY; IN VITRO STUDY; MICROARRAY ANALYSIS; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; DNA MICROARRAY; DRUG EFFECTS; GENE EXPRESSION REGULATION; IMMUNOLOGY; INSTITUTE FOR CANCER RESEARCH MOUSE; PHYSIOLOGY;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; DENDRITIC CELLS; FEMALE; GENE EXPRESSION REGULATION; HEPARITIN SULFATE; MICE; MICE, INBRED ICR; MYELOID DIFFERENTIATION FACTOR 88; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RABIES VACCINES; TOLL-LIKE RECEPTORS; TRANSCRIPTOME;

EID: 84922550971     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.4161/21645515.2014.980682     Document Type: Article

References (64)

1. Carl RA, Kristina KP, Mangala R and Steven GR. Adjuvants for human vaccines. Curr Opin Immunol 2012; 23:1-6
2. Lamine Mbow M, De Gregorio E, Valiante NM, Rappuoli R. New adjuvants for human vaccines. Curr Opin Immunol 2010; 22:411-6; PMID:20466528; http://dx.doi.org/10.1016/j.coi.2010.04.004
3. Janeway CA Jr. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb Symp Quant Biol 1989; 54(Pt 1):1-13; PMID:2700931; http://dx.doi.org/10.1101/SQB.1989. 054.01.003
4. Brewer JM, Alexander J. Cytokines and the mechanisms of action of vaccine adjuvants. Cytokines Cell Mol Ther 1997; 3:233-46; PMID:9740352
5. Takeda K, Kaisho T, Akira S. Toll-like receptors. Annu Rev Immunol 2003; 21:335-76; PMID:12524386; http://dx.doi.org/10.1146/annurev.immunol.21.120601. 141126
6. Iwasaki A, Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat Immunol 2004; 5 (October (10)):987-95; PMID:15454922; http://dx. doi.org/10.1038/ni1112
7. van Duin D, Medzhitov R, Shaw AC. Triggering TLR signaling in vaccination. Trends Immunol 2006; 27 (January (1)):49-55; PMID:16310411; http://dx.doi. org/10.1016/j.it.2005.11.005
8. Takeda K, Takeuchi O, Akira S. Recognition of lipopeptides by toll-like receptors. J Endotoxin Res 2002; 8 (6):459-63; PMID:12697090; http://dx.doi.org/ 10.1179/096805102125001073
9. Cluff CW, Baldridge JR, Stover AG, Evans JT, Johnson DA, Lacy MJ, Clawson VG, Yorgensen VM, Johnson CL, Livesay MT, et al. Synthetic toll-like receptor 4 agonists stimulate innate resistance to infectious challenge. Infect Immun 2005; 73(May (5)):3044-52; PMID:15845512; http://dx.doi.org/10.1128/IAI.73. 5.3044-3052.2005
10. Huleatt JW, Jacobs AR, Tang J, Desai P, Kopp EB, Huang Y, Song L, Nakaar V, Powell TJ. Vaccination with recombinant fusion proteins incorporating Tolllike receptor ligands induces rapid cellular and humoral immunity. Vaccine 2007; 25(January 8 (4)):763-75; PMID:16968658; http://dx.doi.org/10.1016/j.vaccine. 2006.08.013
11. Trumpfheller C, Caskey M, Nchinda G, Longhi MP, Mizenina O, Huang Y, Schlesinger SJ, Colonna M, Steinman RM. The microbialmimic poly IC induces durable and protective CD4C T cell immunity together with a dendritic cell targeted vaccine. Proc Natl Acad Sci USA 2008; 105(February 19 (7)):2574-9; PMID:18256187; http://dx.doi.org/10.1073/ pnas.0711976105
12. Wille-Reece U, Flynn BJ, Lore K, Koup RA, Kedl RM, Mattapallil JJ, Weiss WR, Roederer M, Seder RA. HIV Gag protein conjugated to a Toll-like receptor 7/8 agonist improves the magnitude and quality of Th1 and CD8C T cell responses in nonhuman primates. Proc Natl Acad Sci USA 2005; 102(October 18 (42)):15190-4; PMID:16219698; http://dx.doi.org/ 10.1073/pnas.0507484102
13. Waag DM, McCluskie MJ, Zhang N, Krieg AM. A CpG oligonucleotide can protect mice from a low aerosol challenge dose of Burkholderia mallei. Infect Immun 2006; 74(March (3)):1944-8; PMID:16495571; http://dx.doi.org/10.1128/IAI.74.3. 1944-1948.2006
14. Bendelac A, Medzhitov R. Adjuvants of immunity: harnessing innate immunity to promote adaptive immunity. J Exp Med 2002; 195:F19-23; PMID:11877490; http://dx.doi.org/10.1084/jem.20020073
15. Cella M, Sallusto F, Lanzavecchia A. Origin, maturation and antigen presenting function of dendritic cells. Curr Opin Immunol 1997; 9:10-16; PMID:9039784; http://dx.doi.org/10.1016/S0952-7915(97)80153-7
16. Abbas AK, Murphy KM, Sher A. Functional diversity of helper T lymphocytes. Nature 1996; 383:787-93; PMID:8893001; http://dx.doi.org/10.1038/383787a0
17. Wrenshall LE, Platt JL, Stevens ET, Wight TN, Miller JD. Propagation and control of T-cell responses by heparan sulfate-bound IL-2. J. Immunol 2003; 170 (11): 5470-4; PMID:12759423; http://dx.doi.org/ 10.4049/jimmunol.170.11.5470
18. Brennan TV, Lin L, Huang X, Cardona D M, Li Z, Dredge K, Yang Y. Heparan sulfate, an endogenous TLR4 agonist, promotes acute GVHD after allogeneic stem cell transplantation. Blood 2012; 120(14); 2899-908; PMID:22760779; http://dx.doi.org/10.1182/ blood-2011-07-368720
19. Ihrcke NS, Wrenshall LE, Lindman BJ, Platt JL. Role of heparan sulfate in immune system-blood vessel interactions. Immunol 1993; Today 14:500; PMID:8274190
20. Gilat D, Cahalon L, Hershkoviz R, Lider O. Interplay of T cells and cytokines in the context of enzymatically modified extracellular matrix. Immunol 1996; Today 17:16; PMID:8652044
21. Kato M, Wang H, Kainulainen V, Fitzgerald ML, Ledbetter S, Ornitz DM, Bernfield M. Physiological degradation converts the soluble syndecan-1 ectodomain from an inhibitor to a potent activator of FGF-2. Nat Med 1998; 4:691; PMID:9623978
22. Subramanian SV, Fitzgerald ML, Bernfield M. Regulated shedding of syndecan-1 and -4 ectodomains by thrombin and growth factor receptor activation. J Biol Chem 1997; 272:14713; PMID:9169435
23. Platt JL, Dalmasso AP, Lindman BJ, Ihrcke NS, Bach FH. The role of C5a and Ab in the release of heparan sulfate from endothelial cells. Eur J Immunol 1991; 21:2887; PMID:1936126; http://dx.doi.org/10.1002/ eji.1830211135
24. Ihrcke NS, Parker W, Reissner KJ, Platt JL. Regulation of platelet heparanase during inflammation: role of pH and proteinases. J Cell Physiol 1998; 175:255; PMID:9572470; http://dx.doi.org/10.1002/(SICI) 1097-4652(199806)175:3%3c255::AID-JCP3%3e3.0. CO;2-N
25. Gotte M. Syndecans in inflammation. FASEB J 2003; 17, 575-91; PMID:12665470; http://dx.doi.org/ 10.1096/fj.02-0739rev
26. Johnston B, Butcher EC. Chemokines in rapid leukocyte adhesion triggering and migration. Semin Immunol 2002; 14:83-92; PMID:11978080; http://dx.doi. org/10.1006/smim.2001.0345
27. Wrenshall LE, Cerra FB, Singh RK, Platt JL. Heparan sulfate initiates signals in murine macrophages leading to divergent biological outcomes. J Immunol 1995; 154:871; PMID:7814890
28. Wrenshall LE, Cerra FB, Carlson A, Bach FH, Platt JL. Regulation of murine splenocyte responses by heparan sulfate. J Immunol 1991; 147:455; PMID:1830063
29. Wrenshall LE, Stevens RB, Cerra FB, Platt JL.Modulation of macrophage and B cell function by glycosaminoglycans. J Leukocyte Biol 1999; 66:391; PMID:10496308
30. Kodaira Y, Nair SK, Wrenshall LE, Gilboa E, Platt JL. Phenotypic and functional maturation of dendritic cells mediated by heparan sulfate. J Immunol 2000; 165(3): 1599-604; PMID:10903769; http://dx.doi.org/ 10.4049/jimmunol.165.3.1599
31. Lan Y, Wang H-X, Wu MN, Hu N-Z, Hu Y-Z. Effect of low molecular weight heparan sulfate, an endogenous danger signal, as an immunological adjuvant. Chin J Biologicals 2011; January 24(1):5-9
32. Granucci F, Ferrero E, Foti M, Aggujaro D, Vettoretto K, Ricciardi-Castagnoli P. Early events in dendritic cell maturation induced by LPS. Microbes Infect 1999; 1:1079; PMID:10572310; http://dx.doi.org/10.1016/ S1286-4579(99)00209-9
33. Sparwasser T, Koch ES, Vabulas RM, Heeg K, Lipford GB, Ellwart JW, Wagner H. Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells. Eur J Immunol 1998; 28:2045; PMID:9645386; http://dx. doi.org/10.1002/(SICI)1521-4141(199806)28:06%3c 2045::AID-IMMU2045%3e3.0.CO;2-8
34. Mosca F, Tritto E, Muzzi A, Monaci E, Bagnoli F, Iavarone C, O'Hagan D, Rappuoli R, De Gregorio E. Molecular and cellular signatures of human vaccine adjuvants. Proc Natl Acad Sci USA 2008; 105(30), 10501-6; PMID:18650390; http://dx.doi.org/ 10.1073/pnas.0804699105
35. De Gregorio E, Tritto E, Rappuoli R. Alum adjuvanticity: unraveling a century old mystery. Eur J Immunol 2008; 38(8):2068-71; PMID:18651701; http://dx.doi. org/10.1002/eji.200838648
36. Iwasaki A, Medzhitov R. Regulation of adaptive immunity by the innate immune system. Science 2010; 327 (5963):291-5; PMID:20075244; http://dx.doi.org/ 10.1126/science.1183021
37. Casella CR, Mitchell TC. Putting endotoxin to work for us:monophosphoryl lipid A as a safe and effective vaccine adjuvant. Cell Mol Life Sci 2008; 65:3231-40; PMID:18668203; http://dx.doi.org/10.1007/s00018-008-8228-6
38. Cluff CW. Monophosphoryl lipidA(MPL) as an adjuvant for anti-cancer vaccines: clinical results. Adv Exp Med Biol 2010; 667:111-23; PMID:20665204; http:// dx.doi.org/10.1007/978-1-4419-1603-7-10
39. Piccinini AM, Midwood KS. DAMPening inflammation by modulating TLR signalling. Mediat Inflamm 2010; pii: 672395.Epub 2010 Jul 13; PMID: 20706656; http://dx.doi.org/10.1155/2010/672395
40. Kis-Toth K, Tsokos GC. Dendritic cell function in lupus: Independent contributors or victims of aberrant immune regulation. Autoimmunity 2010; 43(2):121-30; PMID:20102311; http://dx.doi.org/10.3109/ 08916930903214041
41. Schaefer L, Babelova A, Kiss E, Hausser HJ, Baliova M, Krzyzankova M, Marsche G, Young MF, Mihalik D, Gotte M, et al. The matrix component biglycan is proinflammatory and signals through Toll-like receptors 4 and 2 in macrophages. J Clin Invest 2005; 115:2223-33; PMID:16025156; http://dx.doi.org/ 10.1172/JCI23755
42. Termeer C, Benedix F, Sleeman J, Fieber C, Voith U, Ahrens T, Miyake K, Freudenberg M, Galanos C, Simon JC. Oligosaccharides of Hyaluronan activate dendritic cells via toll-like receptor 4. J Exp Med 2002; 195:99-111; PMID:11781369; http://dx.doi.org/ 10.1084/jem.20001858
43. Johnson GB, Brunn GJ, Kodaira Y, Platt JL. Receptormediated monitoring of tissue well-being via detection of soluble heparan sulfate by Toll-like receptor 4. J Immunol 2002; 168:5233-9; PMID:11994480; http:// dx.doi.org/10.4049/jimmunol.168.10.5233
44. Kawai T, Akira S. Pathogen recognition with Toll-like receptors. Curr Opin Immunol 2005; 17:338-44
45. Kawai T, Adachi O, Ogawa T, Takeda K, Akira S. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 1999; 11:115-22; PMID:10435584; http://dx.doi.org/10.1016/S1074-7613(00)80086-2
46. Akira S, Takeda K. Functions of toll-like receptors: lessons from KO mice. C R Biol 2004; 327:581-9; PMID:15330257
47. Akira S1, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell 2006; Feb 24;124 (4):783-801; PMID:16497588; http://dx.doi.org/ 10.1016/j.cell.2006.02.015
48. Yamamoto M, Sato S, Hemmi H, Hoshino K, Kaisho T, Sanjo H, Takeuchi O, Sugiyama M, Okabe M, Takeda K, Akira S. Role of adaptor TRIF in the MyD88-independent Toll-like receptor signaling pathway. Science 2003; 301:640-3; PMID:12855817; http://dx.doi.org/10.1126/science.1087262
49. Kaisho T, Takeuchi O, Kawai T, Hoshino K, Akira S. Endotoxin-induced maturation of MyD88-deficient dendritic cells. J Immunol 2001; 166(9):5688-94; PMID:11313410; http://dx.doi.org/10.4049/jimmunol. 166.9.5688
50. Kolanowski ST, Dieker MC, Lissenberg-Thunnissen SN, van Schijndel GM, van Ham SM, Brinke AT. TLR4-mediated pro-inflammatory dendritic cell differentiation in humans requires the combined action of MyD88 and TRIF. Innate Immun 2014; 20(4):423-30; PMID:23941760; http://dx.doi.org/10.1177/ 1753425913498626
51. Shen H, Tesar BM, Walker WE, Goldstein DR. Dual signaling of MyD88 and TRIF is critical for maximal TLR4-induced dendritic cell maturation. J Immunol 2008; 181:1849-58; PMID:18641322; http://dx.doi. org/10.4049/jimmunol.181.3.1849
52. Hoebe K, Janssen EM, Kim SO, Alexopoulou L, Flavell RA, Han J, Beutler B. Upregulation of costimulatory molecules induced by lipopolysaccharide and doublestranded RNA occurs by Trif-dependent and Trif-independent pathways. Nat Immunol 2003; 4:1223-9; PMID:14625548; http://dx.doi.org/10.1038/ni1010
53. Akbarshahi H, Axelsson JB, Said K, Malmstrom A, Fischer H, Andersson R. TLR4 dependent heparan sulphate- induced pancreatic inflammatory response is IRF3-mediated. J Transl Med 2011; 9:219; PMID:22188870; http://dx.doi.org/10.1186/1479-5876-9-219
54. Gautier G, Humbert M, Deauvieau F, Scuiller M, Hiscott J, Bates EEM, Trinchieri G, Caux C, Garrone P. A type I interferon autocrine-paracrine loop is involved in Toll-like receptor-induced interleukin-12p70 secretion by dendritic cells. J Exp Med 2005; 201:1435-46; PMID:15851485; http://dx.doi.org/10.1084/jem.2004 1964
55. Groom JR, Luster AD. CXCR3 in T cell function. Exp Cell Res 2011; 317:620-31; PMID:21376175; http:// dx.doi.org/10.1016/j.yexcr.2010.12.017
56. Orr MT, Duthie MS, Windish HP, Lucas EA, Guderian JA, Hudson TE, Coler RN. MyD88 and TRIF synergistic interaction is required for TH1-cell polarization with a synthetic TLR4 agonist adjuvant. Eur J Immunol 2013; 43 (9):2398-408; PMID:23716300; http://dx.doi.org/ 10.1002/eji.201243124
57. Mata-Haro V, Cekic C, Martin M, Chilton PM, Casella CR, Mitchell TC. The vaccine adjuvant monophosphoryl lipid A as a TRIF-biased agonist of TLR4. Science 2007; 316:1628-32; PMID:17569868; http:// dx.doi.org/10.1126/science.1138963
58. Cekic C, Casella CR, Eaves CA, Matsuzawa A, Ichijo H, Mitchell TC. Selective activation of the p38 MAPK pathway by synthetic monophosphoryl lipid A. J Biol Chem 2009; 284:31982-91; PMID:19759006; http:// dx.doi.org/10.1074/jbc.M109.046383
59. Persing DH, Coler RN, Lacy MJ, Johnson DA, Baldridge JR, Hershberg RM, Reed SG. Taking toll: lipid Amimetics as adjuvants and immunomodulators. Trends Microbiol 2002; 10:S32-7; PMID:12377566; http://dx.doi.org/10.1016/S0966-842X(02)02426-5
60. Gandhapudi SK, Chilton PM, Mitchell TC. TRIF is required for TLR4 mediated adjuvant effects on T cell clonal expansion. PLoS One 2013; 8(2):e56855; PMID:23457630; http://dx.doi.org/10.1371/journal. pone.0056855
61. Rhee EG, Kelley RP, Agarwal I, Lynch DM, La Porte A, Simmons NL, Clark SL, Barouch DH. TLR4 ligands augment antigen-specific CD8C T lymphocyte responses elicited by a viral vaccine vector. J Virol 2010; 84:10413-9; PMID:20631129; http://dx.doi. org/10.1128/JVI.00928-10
62. Athanasia S, Xiaowei W, Huajun W, Brian S. Primer-Bank: a resource of human and mouse PCR primer pairs for gene expression detection and quantification. Nucl Acids Res 2010; 38:D792-9; PMID:19906719; http://dx.doi.org/10.1093/nar/gkp1005
63. Athanasia S, Xiaowei W, Huajun W, Stefan D, Tara T, Brian S. A comprehensive collection of experimentally validated primers for Polymerase chain reaction quantitation of murine transcript abundance. BMC Genomics 2008; 9:633; PMID:19108745; http://dx.doi.org/ 10.1186/1471-2164-9-633
64. Xiaowei W, Brian S. A PCR primer bank for quantitative gene expression analysis. Nucleic Acids Res 2003; 31(24):e154; 1-8; PMID:14654707; http://dx.doi.org/ 10.1093/nar/gng154